6UE-17246-77719
4 vaccinations
10 coded responses
51 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 775 / TX
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Moderna
-
2021-03-04
Registered in v-safe
- 2021-03-04
- 2021-03-05
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: Eye swelling, Swollen tongue — Feeling: GoodFree text: Slight Swelling mostly eyes & toungueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-03-30
Dose 2 — Moderna
- 2021-03-31
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Eye swelling, Mouth swelling — Feeling: Good · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen eyes & mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-21
- 2021-04-27
- 2021-05-04
- 2021-05-13
- 2021-07-01
-
2021-09-29
Survey response — 6 months, dose 2MedDRA: Amenorrhoea, Postmenopausal haemorrhage, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Actually between dose #1 & 2 on March 15th experienced a post menopause bleed following 17 months of no menstrual activity. Read report of many women experienced menstrual anomalies related to covid vaccines. · Healthcare visit (other): Pelvic ultrasoundMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-04
Call successfulParticipant prefers to complete VAERS report online
-
2022-01-11
Dose 3 — Moderna
- 2022-01-11
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-01-13
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: GoodFree text: Loss of appetiteMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
- 2022-01-15
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-25
-
2022-02-01
Survey response — day 21, dose 3MedDRA: White blood cell count decreased — Feeling: GoodFree text: Low white blood cell count (WBC 3.1)MedDRA releases: 2024-11 · check-in free text available
- 2022-02-08
- 2022-02-15
- 2022-02-23
- 2022-04-12
-
2022-10-10
Dose 4 — Moderna
- 2022-10-10
-
2022-10-11
Survey response — days 1–6 daily, dose 4MedDRA: Eye swelling — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Slightly swollen eyesMedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
- 2022-10-13
-
2022-10-14
Survey response — days 1–6 daily, dose 4MedDRA: Transient lingual papillitis — Feeling: GoodFree text: A singular irksome Transient lingual papillitis for past 3 daysMedDRA releases: 2024-11 · check-in free text available
- 2022-10-16
- 2022-10-17
-
2022-10-24
Survey response — day 14, dose 4MedDRA: Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Post nasal drip. CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Survey response — day 21, dose 4MedDRA: Respiratory tract congestion, Sinus congestion, Upper-airway cough syndrome — Feeling: Good · Be unable to do your normal daily activitiesFree text: Congestion, blocked sinuses and frequent post nasal dripMedDRA releases: 2024-11 · check-in free text available
- 2022-11-07
-
2022-11-14
Survey response — day 35, dose 4MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: extreme sinusitusMedDRA releases: 2024-11 · check-in free text available
- 2022-11-21
- 2023-01-09
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-30 | Moderna | |
| 3 | 2022-01-11 | Moderna | No |
| 4 | 2022-10-10 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Slight Swelling mostly eyes & toungue
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen eyes & mouth
Release 9 — 6 months, dose 2
Symptoms: Actually between dose #1 & 2 on March 15th experienced a post menopause bleed following 17 months of no menstrual activity. Read report of many women experienced menstrual anomalies related to covid vaccines.
Healthcare visit (other): Pelvic ultrasound
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Loss of appetite
Release 11 — day 21, dose 3
Symptoms: Low white blood cell count (WBC 3.1)
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Slightly swollen eyes
Systemic reaction (other): A singular irksome Transient lingual papillitis for past 3 days
Release 12 — day 14, dose 4
Symptoms: Post nasal drip. Congestion
Release 12 — day 21, dose 4
Symptoms: Congestion, blocked sinuses and frequent post nasal drip
Release 12 — day 35, dose 4
Symptoms: extreme sinusitus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Amenorrhoea | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SD | White blood cell count decreased | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Eye swelling | ✓ | ✓ | ✓ |
| SRO | Mouth swelling | ✓ | ✓ | ✓ |
| SRO | Swollen tongue | ✓ | ✓ | ✓ |
| SRO | Transient lingual papillitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release